Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ian Rabb Insider Profile
4 Followers
Ian Rabb, Chief Clinical Officer at Universal Ibogaine Inc, holds 1.30M shares in Universal Ibogaine Inc (Ticker: TSE:IBO). Most recently, Ian Rabb Bought C$200,000 shares of Universal Ibogaine Inc on Oct 16, 2022 for an estimated value of 5.00K.
Ian Rabb Universal Ibogaine Inc (IBO)Chief Clinical Officer
Universal Ibogaine Inc (IBO)
Chief Clinical Officer
Not Ranked
Ranked #43,716 out of 98,042 Corporate Insiders
Ian Rabb has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chief Clinical Officer
Roles that Ian Rabb holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 04, 2021 - Dec 04, 2022
Return:-75.00%
The most profitable trade made by Ian Rabb
Ian Rabb's Trading History
List of latest transactions for each holding click on a transaction to see Ian Rabb's performance on stock
You May Also Like
Ian Rabb insider profile FAQ
What is the percentage of profitable transactions made by Ian Rabb?
The percentage of profitable transactions made by Ian Rabb is ―.
What is the average return per transaction made by Ian Rabb?
The average return per transaction made by Ian Rabb is ―.
What stocks does Ian Rabb hold?
Ian Rabb holds: TSE:IBO stocks.
What was Ian Rabb’s latest transaction?
Ian Rabb latest transaction was an Informative Buy of C$5.00K.
What was Ian Rabb's most profitable transaction?
Ian Rabb’s most profitable transaction was an Informative Buy of TSE:IBO stock on December 4, 2021. The return on the trade was -75.00%.
What is Ian Rabb's role in Universal Ibogaine Inc?
Ian Rabb's role in Universal Ibogaine Inc is Chief Clinical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.